In lines with the previous studies, our study demonstrates for the first time that higher SLC38A7 expression is associated with a poor survival of GC patients and overexpression of SLC38A7 strengthens cell viability, migration, invasion, oxidative phosphorylation, and mitochondrial function. This evidence concerns the gene SLC38A7 and gastric cancer.